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Supplementary	 data,	 Figure	 1:	 Integrity	 of	 the	 lipid	 mediators	 was	 assessed	 using	
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Supplementary	 data,	 Figure	 3.	 Effects	 of	 SPMs	 on	 microvascular	 hyper	 reactivity	 as	
determined	by	laser	Doppler.		
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